
Brown–Forman (BF-B)
NYSEConsumer StaplesBeverages - Wineries & DistilleriesSnapshot 2026-07-07
Reading BF-B? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track BF-B free→
NYSEConsumer StaplesBeverages - Wineries & DistilleriesSnapshot 2026-07-07
Reading BF-B? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track BF-B free→QuarterlyIQ Insights · BF-B
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 12 valuation methods, at three horizons. Current price $25.89. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $26 BF-B trades at 17× p/e, below its 19× p/e peer median. Our $29 fair value sits above the price. It's a high-confidence read. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
These describe the expectations embedded in the price, not a forecast of the move. Reverse-DCF base: $1.66/sh owner earnings.
Looks cheaper than most peers in the same business.
Around its own typical valuation.
Trailing four: 2025-Q3, 2026-Q1, 2026-Q2, 2026-Q3
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| dcf fcfe | 12M | $72.60 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $79.50 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $29.38 | — | — | TTM | high |
| graham number | 12M | $17.29 | — | — | TTM | high |
| Peer EV/EBITDA | 12M | $42.63 | 16.9 | 2.75 | TTM | high |
| Peer P/FCF | 12M | $39.24 | 20.3 | 1.93 | TTM | high |
| Peer P/E | 12M | $29.46 | 19.3 | 1.53 | TTM | high |
| Peer P/S | 12M | $14.43 | 1.7 | 8.49 | TTM | high |
| PEG | 12M | $32.12 | 21.0 | 1.53 | TTM | high |
| residual income | 12M | $11.45 | — | — | TTM | high |
| Own P/E history | 12M | $27.25 | 17.8 | 1.53 | TTM | high |
| triangulated | 12M | $29.36 | 19.3 | 1.52 | Triangulated | high |
| Peer P/FCF | 3Y | $59.68 | 20.3 | 2.93 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $34.21 | 19.3 | 1.78 | Analyst | medium |
| Peer P/S | 3Y | $14.97 | 1.7 | 8.80 | Analyst | medium |
| PEG | 3Y | $37.31 | 21.0 | 1.78 | Analyst | medium |
| Own P/E history | 3Y | $31.65 | 17.8 | 1.78 | Analyst | medium |
| Peer P/FCF | 5Y | $78.93 | 20.3 | 3.88 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $35.03 | 19.3 | 1.82 | Analyst | high |
| Peer P/S | 5Y | $15.33 | 1.7 | 9.02 | Analyst | high |
| PEG | 5Y | $38.21 | 21.0 | 1.82 | Analyst | high |
| Own P/E history | 5Y | $32.41 | 17.8 | 1.82 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.